))
Ep. 52 - Khoo Shih on Scaling Singapore Biotech
Manage episode 416005602 series 3571902
Innehåll tillhandahållet av BioCentury. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av BioCentury eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.
Success for the Singapore biotech project will take a global network, one which Khoo Shih and other prominent drivers of the local ecosystem are keen to leverage to bring the right combination of talent, experience and capital to the growing hub. Speaking on The BioCentury Show, Khoo Shih, CEO of investment firm ClavystBio, laid out the strategy for capitalizing on the ascendant energy and attention being devoted to Singapore biotech. While the goal continues to be to create companies that solve global problems and have a global outreach, she said the path involves bringing in international life science investors from day one.
View full story: https://www.biocentury.com/article/651376
#biotech #biopharma #pharma #TheBioCenturyShow
00:00 – Intro
04:48 – ClavystBio
08:18 – Why Singapore
19:07 – 65Labs Incubator
23:20 – Growing the Ecosystem
Kapitel
1. Introduction (00:00:00)
2. ClavystBio (00:04:48)
3. Why Singapore (00:08:18)
4. 65Labs Incubator (00:19:07)
5. Growing the Ecosystem (00:23:20)
22 episoder
Dela
